Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney Sells 27,243 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 27,243 shares of the stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $15.43, for a total transaction of $420,359.49. Following the completion of the transaction, the president now directly owns 2,276,732 shares of the company’s stock, valued at $35,129,974.76. This trade represents a 1.18 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total value of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Stock Up 1.9 %

Shares of NASDAQ ALHC opened at $15.79 on Friday. The stock has a market capitalization of $3.03 billion, a P/E ratio of -20.51 and a beta of 1.49. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $16.25. The company has a 50-day moving average price of $14.38 and a 200-day moving average price of $12.41. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60.

Wall Street Analysts Forecast Growth

Several analysts recently commented on ALHC shares. Barclays raised their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research note on Friday, February 28th. JPMorgan Chase & Co. increased their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a research note on Thursday, March 6th. Bank of America raised their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a research note on Tuesday, March 4th. Stifel Nicolaus boosted their price target on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Finally, Piper Sandler increased their price objective on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $14.83.

Institutional Trading of Alignment Healthcare

Hedge funds have recently bought and sold shares of the business. Mackenzie Financial Corp lifted its stake in shares of Alignment Healthcare by 149.8% during the 4th quarter. Mackenzie Financial Corp now owns 85,175 shares of the company’s stock valued at $958,000 after buying an additional 51,084 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Alignment Healthcare by 15.9% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 263,203 shares of the company’s stock worth $2,961,000 after buying an additional 36,151 shares in the last quarter. Voloridge Investment Management LLC bought a new stake in Alignment Healthcare during the fourth quarter valued at approximately $189,000. Squarepoint Ops LLC lifted its holdings in shares of Alignment Healthcare by 414.6% during the 4th quarter. Squarepoint Ops LLC now owns 198,309 shares of the company’s stock worth $2,231,000 after acquiring an additional 159,774 shares during the last quarter. Finally, Two Sigma Investments LP bought a new position in shares of Alignment Healthcare during the 4th quarter valued at about $258,000. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.